Mizuho lowered the firm’s price target on Humana (HUM) to $310 from $345 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana price target lowered to $231 from $250 at Deutsche Bank
- Humana’s Hold Rating: Balancing Positive Earnings with Strategic Challenges
- Humana’s Strategic Focus on Medicare Advantage and Future Margin Expansion Amidst Uncertain Guidance
- Humana’s Growth Prospects and Risks: Hold Rating Amid Unclear 2026 Projections and MLR Challenges
- Humana Reports Strong Q3 2025 Results Amid Strategic Growth